NCT03929770 (SG cath) is a NA clinical trial of with pause in Swan-Ganz Catheter Insertion, sponsored by Seoul National University Hospital.

Who is sponsoring NCT03929770?

NCT03929770 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT03929770?

Interventions in NCT03929770: with pause, without pause.

What condition does NCT03929770 study?

NCT03929770 studies Swan-Ganz Catheter Insertion.

Is NCT03929770 still recruiting?

NCT03929770 is currently status unknown. Last updated 1 May 2019.

Last reviewed 2019-05-01 · How we verify

NCT03929770: SG cath

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Swan-Ganz Catheter Insertion

Status unknown NA Last updated 1 May 2019

What this trial tests

NA trial testing with pause in Swan-Ganz Catheter Insertion in 112 participants. Status unknown.

Timeline

29 April 2019

Primary endpoint
30 March 2020

30 April 2020

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	112
Start date	29 April 2019
Primary completion	30 March 2020
Estimated completion	30 April 2020
Sites	1 location across South Korea

Drugs / interventions tested

with pause
without pause

Conditions studied

Swan-Ganz Catheter Insertion — all drugs for Swan-Ganz Catheter Insertion →

Sponsor

Seoul National University Hospital

Who can join

18 and older, any sex, with Swan-Ganz Catheter Insertion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this prospective randomized controlled study is to investigate the effect of pause of advancement of the Swan-Ganz catheter, which is to check whether the Swan-Ganz catheter arrive exactly at the right ventricle or not, on success rate of final placement and required time in Swan-Ganz catheterization. The question which the investigators are trying to answer is: Continuous advancement of Swan-Ganz catheter without intended pause in the right ventricle to check whether the Swan-Ganz catheter arrive exactly at the right ventricle will decrease the trial number and required time to success final placement of Swan-Ganz catheter?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03929770 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 1 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03929770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing